[Skip to Content](https://www.sigmaaldrich.com#main-content)
[](https://www.sigmaaldrich.com/US/en)
Products
Cart0
USEN
Products
ProductsApplicationsServicesResourcesSupport
[Login / Register](https://www.sigmaaldrich.com/oidc-sign-in)
[Order Lookup](https://www.sigmaaldrich.com/US/en/order-lookup)
[Quick Order](https://www.sigmaaldrich.com/US/en/quick-order)
Cart0
[Home](https://www.sigmaaldrich.com/US/en)[Applications](https://www.sigmaaldrich.com/US/en/applications)[Pharmaceutical & Biopharmaceutical Manufacturing](https://www.sigmaaldrich.com/US/en/applications/pharmaceutical-and-biopharmaceutical-manufacturing)Blood Plasma Fractionation
# Blood Plasma Fractionation
Plasma fractionators play a critical role in the treatment of rare life-threatening conditions. Consistent, reliable performance is key to plasma fractionation, posing challenges that must be met in order to better serve patients around the globe: improving yield, maintaining process economics, and managing ever-increasing regulatory requirements. Choosing the right partner with deep understanding of these challenges is vital, offering fractionators a gateway to new solutions and resources that can enhance their full range of blood plasma products.
* * *
## Related Products
Slide 1 of 18
1 of 5
[
\
Millipore
\
1.16881
\
Fractogel® EMD TMAE (M)](https://www.sigmaaldrich.com/US/en/product/mm/116881)
Quick View
[
\
Millipore
\
1.16887
\
Fractogel® EMD TMAE (S)](https://www.sigmaaldrich.com/US/en/product/mm/116887)
Quick View
[
\
Millipore
\
1.10316
\
Fractogel® EMD TMAE Hicap (M)](https://www.sigmaaldrich.com/US/en/product/mm/110316)
Quick View
[
\
Millipore
\
P3B030A00
\
Pellicon® 3 Cassette with Biomax® Membrane](https://www.sigmaaldrich.com/US/en/product/mm/p3b030a00)
Quick View
[
\
Millipore
\
P3B010A05
\
Pellicon® 3 Cassette with Biomax® Membrane](https://www.sigmaaldrich.com/US/en/product/mm/p3b010a05)
Quick View
[
\
Millipore
\
P3B050A01
\
Pellicon® 3 Cassette with Biomax® Membrane](https://www.sigmaaldrich.com/US/en/product/mm/p3b050a01)
Quick View
[
\
Millipore
\
P3B030A01
\
Pellicon® 3 Cassette with Biomax® Membrane](https://www.sigmaaldrich.com/US/en/product/mm/p3b030a01)
Quick View
[
\
Millipore
\
P3B010A01
\
Pellicon® 3 Cassette with Biomax® Membrane](https://www.sigmaaldrich.com/US/en/product/mm/p3b010a01)
Quick View
[
\
Millipore
\
CM06100
\
Cogent® M1 100V](https://www.sigmaaldrich.com/US/en/product/mm/cm06100)
Quick View
[
\
Millipore
\
CM06230
\
Cogent® M1 230V](https://www.sigmaaldrich.com/US/en/product/mm/cm06230)
Quick View
[
\
Millipore
\
120650
\
Eshmuno® CMX Resin](https://www.sigmaaldrich.com/US/en/product/mm/120650)
Quick View
[
\
Millipore
\
1.20083
\
Eshmuno® CPX Resin](https://www.sigmaaldrich.com/US/en/product/mm/120083)
Quick View
[
\
Millipore
\
VPMH203000
\
Viresolve® Pro+ Magnus Holder](https://www.sigmaaldrich.com/US/en/product/mm/vpmh203000)
Quick View
[
\
Millipore
\
VPMH103000
\
Viresolve® Pro Magnus Holder](https://www.sigmaaldrich.com/US/en/product/mm/vpmh103000)
Quick View
[
\
Millipore
\
VPMH107000
\
Viresolve® Pro Magnus Holder](https://www.sigmaaldrich.com/US/en/product/mm/vpmh107000)
Quick View
[
\
Millipore
\
VPMH105000
\
Viresolve® Pro Magnus Holder](https://www.sigmaaldrich.com/US/en/product/mm/vpmh105000)
Quick View
[
\
Millipore
\
VPMH205000
\
Viresolve® Pro+ Magnus Holder](https://www.sigmaaldrich.com/US/en/product/mm/vpmh205000)
Quick View
[
\
Millipore
\
VPMH207000
\
Viresolve® Pro+ Magnus Holder](https://www.sigmaaldrich.com/US/en/product/mm/vpmh207000)
Quick View
* * *
## Featured Categories
[](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/buffer-media-prep/single-use-mixers)
[Single-Use Mixers](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/buffer-media-prep/single-use-mixers)
Explore Mobius® single-use mixing solutions for pharmaceutical ingredient blending and process solution preparation.
[Shop Products](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/buffer-media-prep/single-use-mixers)
[](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/sterile-filtration-and-bioburden-control/integrity-testers)
[Integrity Testers](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/sterile-filtration-and-bioburden-control/integrity-testers)
Efficient Filter Integrity Testing: Elevate quality control with Integritest® 5, offering bubble point, diffusion, and hydrophobic testing in-line or offline.
[Shop Products](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/sterile-filtration-and-bioburden-control/integrity-testers)
[](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/viral-clearance/virus-inactivation)
[Viral Inactivation](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/viral-clearance/virus-inactivation)
Enhance biopharma safety and compliance with our viral inactivation solutions, including sustainable detergents, low pH treatment, and viral clearance testing services.
[Shop Products](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/viral-clearance/virus-inactivation)
[](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/sterile-filtration-and-bioburden-control/final-sterile-filtration-and-filling)
[Final Sterile Filtration & Filling](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/sterile-filtration-and-bioburden-control/final-sterile-filtration-and-filling)
Enhance final filtration and sterile fill processes with pre-sterilized, single-use systems for optimized operations.
[Shop Products](https://www.sigmaaldrich.com/US/en/products/pharma-and-biopharma-manufacturing/sterile-filtration-and-bioburden-control/final-sterile-filtration-and-filling)
* * *
Overview
Related Articles & Protocols
Support
## Immunoglobulin
Polyclonal immunoglobulin G (IgG) is the primary high-value product for all plasma manufacturers. Today, immunoglobulin is administered in higher concentration dosages; this requires formulations which are well-tolerated by the patient. Key parameters for tolerability include:
- High purity
- Low immunoglobulin A and M (igA, IgM) content
- Low prekallikrein activator (PKA) content
- Low anticardiolipin antibody (ACA) content
- Low isoagglutinin content
The clinical efficacy of IgG is determined by the process and the quality of manufacture. Key features include an intact molecule, physiological sub-class distribution, pH of administration, absence of pyrogens, and low toxic residue content. IgG is currently used to treat primary immunodeficiency (PID), neurological conditions, hematology, and other infectious diseases.
## Albumin
Albumin, often referred to as [HSA (human serum albumen)](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-culture-supplements-and-reagents/albumins-and-transport-proteins?language=en&cmsRoute=products&cmsRoute=cell-culture-and-analysis&cmsRoute=cell-culture-supplements-and-reagents&cmsRoute=albumins-and-transport-proteins&page=1), is a stable protein with a molecular weight of 67 kD. It is sometimes added as a stabilizer for other plasma products, though its therapeutic use is as a fluid replacement treatment to expand blood volume in patients typically traumatized by burns or surgery. Albumin is manufactured in large quantities and is produced by all plasma manufacturers. Frequently, three to five batches per week may be manufactured in both low and high concentrations.
While raw plasma contains around 35–50 g of albumin per liter, 25–40% of that volume is lost during the actual fractionation process. This can lead fractionators to consider a chromatography method instead of Cohn fractionation, as chromatography has more favorable loss percentages of around 15–20%.
## Factor VIII
Improving purity while maintaining specific activity is important in production of Factor VIII (FVIII), an essential blood-clotting protein. Clinical requirements of administration to a patient include low immunogenicity and high purity, which translates to low isoagglutinins and accompanying protein count, no foreign proteins or DNA, and low amounts of chemical residues. The purification process is designed to achieve these requirements:
- Increasing process efficiency and product recovery
- Achieving higher product yield
- Ensuring process safety and reproducibility of multi-strain products
[](https://www.sigmaaldrich.com/documents-search)
[Looking for More Specific Information?](https://www.sigmaaldrich.com/documents-search)
Visit our document search for data sheets, certificates and technical documentation.
[Find Documents](https://www.sigmaaldrich.com/documents-search)
## Related Technical Articles
- [Benefits of Flow Through Polishing Platforms in Downstream Processing](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/analytical-chemistry/flow-through-polishing-platform-benefits)
Minimize bottlenecks in downstream processing. Discover how flow-through technologies increase speed and efficiency, reducing footprint and costs.
- [Impact of DMSO And Freezing Technique in Developing a High Cell Density Cryopreservation Process for Upstream Bioprocessing](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/cell-culture-for-manufacturing/dmso-freezing-technique-high-cell-density-cryopreservation)
Understand how considerations such as DMSO concentrations and freezing techniques are key in the successful implementation of high cell density cryopreservation (HCDC).
- [Seed Train Intensification Using High Cell Density Cryopreservation](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/cell-culture-for-manufacturing/seed-train-intensification-high-cell-density-cryopreservation)
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
- [Advancing Pharmaceutical Life Cycle Assessment (LCA)](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/pharmaceutical-and-biopharmaceutical-manufacturing/advancing-pharmaceutical-life-cycle-assessment)
Get comprehensive life cycle assessment (LCA) and sustainability information meeting pharma regulatory requirements as part of your Emprove® Dossier.
- [Antibody Drug Conjugate Manufacturing](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/pharmaceutical-and-biopharmaceutical-manufacturing/antibody-drug-conjugate-manufacturing)
Antibody Drug Conjugate Manufacturing
- [See All (41)](https://www.sigmaaldrich.com/US/en/search/facet-search?focus=sitecontent&term=facet-search)
### Find More Articles and Protocols
Enter Keywords
Search
* * *
## Related Product Resources
- [Application Note: Integration of Bioburden Reduction and Sterile Filtration in Human Plasma IgG Purification](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/406/992/plasma-igg-sterility-assurance-wp7867en-ms.pdf)
This application note presents an intensified IgG purification process of human plasma from optimized sterile filtration steps.
- [Brochure: Leveraging the Advantages of Single-use in Plasma Processing](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/419/360/single-use-plasma-br2381en-ms.pdf)
Strategically leveraging single-use technologies in key areas of the process provides significant advantages.
- [Brochure: Plasma Processing Capabilities](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/307/599/plasma-trifold-br4462en-ms.pdf)
This brochure outlines the plasma processing capabilities and biomanufacturing products and services.
- [White Paper: Intensification of Human Plasma IgG Purification for Intravenous and Subcutaneous Administration](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/793/932/igg-tmu-whitepaper-wp7867en-ms.pdf)
In this white paper, we present the results from our collaboration with Taipei Medical University to develop and evaluate the reliability and consistency of various new steps to purify plasma-derived IgG.
- [Detergents REACH Information](https://www.sigmaaldrich.com/US/en/campaigns/detergents-reach-information)
Explore our comprehensive portfolio of detergents and surfactants as possible Triton X-100 alternatives for your research applications before the REACH Annex 14 ban takes effect.
- [Brochure: Process Development and Drug Manufacturing](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/428/614/br12856en-support-services-ms.pdf)
Our services guide you at every stage of your equipment and software life cycle.
Page 1 of 2
Page 1 of 2
* * *
## Related Webinars
Slide 1 of 8
[](https://event.on24.com/wcc/r/3238951/8041E2CB39C1E27EFB2CFA25B41F9403)
[Addressing Immunoglobulin (Ig) Purification Challenges with Chromatographic Technologies](https://event.on24.com/wcc/r/3238951/8041E2CB39C1E27EFB2CFA25B41F9403)
A webinar to discuss strategies to address Immunoglobulin (Ig) purification challenges by using Ion Exchange and Affinity chromatography media.
[](https://event.on24.com/wcc/r/3220591/A00DFA05B2378566677C9CDF66F20366)
[Implementing Single-use Technologies - A Plasma Case Study](https://event.on24.com/wcc/r/3220591/A00DFA05B2378566677C9CDF66F20366)
In general the industry is facing pressure to provide a safe, efficacious and secure supply of plasma products on a worldwide basis while at the same time,there is limited capacity for processing.
[](https://event.on24.com/wcc/r/3220342/69E108EF77B7A144460B8F48BBA63521)
[High Viscosity Ultrafiltration Formulation for Plasma IgG and mAbs](https://event.on24.com/wcc/r/3220342/69E108EF77B7A144460B8F48BBA63521)
Ease of administration and high dose applications are driving the bioprocessing industry to formulate higher concentration biotherapeutics.
[](https://event.on24.com/wcc/r/3207100/542BB8F9FDA2873DB2353BAC9A5BD81C)
[Overcoming High Concentration Challenges in IgG Purification](https://event.on24.com/wcc/r/3207100/542BB8F9FDA2873DB2353BAC9A5BD81C)
The plasma industry is looking for process improvements to develop new formulations and dosages with higher concentration for subcutaneous administration, such as for Immunoglobulin.
[](https://event.on24.com/wcc/r/2759384/54475C8436C73E151262D9DF9158EC01?partnerref=email&%3Butm_campaign=PS_BP_MRK_55836_Quality%20by%20Design%20Principles_Nov%2019_Invitation&%3Butm_medium=email&%3Butm_source=EloquaImproved)
[Quality by Design Principles Applied to Sterilizing Filtration](https://event.on24.com/wcc/r/2759384/54475C8436C73E151262D9DF9158EC01?partnerref=email&%3Butm_campaign=PS_BP_MRK_55836_Quality%20by%20Design%20Principles_Nov%2019_Invitation&%3Butm_medium=email&%3Butm_source=EloquaImproved)
The webinar will show how currently available process cGMP information can be practically incorporated into QbD product quality attributes and process parameters.
[](https://event.on24.com/wcc/r/2360759/42E475D21EC1D8F0F421460998A57DE5)
[Design Reduces Contamination Risks in Final Filtration & Filling Processes](https://event.on24.com/wcc/r/2360759/42E475D21EC1D8F0F421460998A57DE5)
We will focus on aspects of new product and system design that help customers meet regulatory expectations and reduce contamination risk while maximizing product recovery.
[](https://event.on24.com/wcc/r/1909380/1C7A40A059D94ACA9213D0AB10C7AE72)
[Sizing, and Operation of Bioprocess Filtration Trains for Optimal Performance](https://event.on24.com/wcc/r/1909380/1C7A40A059D94ACA9213D0AB10C7AE72)
In this webinar we describe a filtration model and test methodology to rapidly and efficiently design an optimal dual-stage filtration process.
[](https://event.on24.com/wcc/r/3241487/B8334C7CA9D3F9FFA43B81F03DD5F23A)
[Your Filter. What’s Best for Your Process?](https://event.on24.com/wcc/r/3241487/B8334C7CA9D3F9FFA43B81F03DD5F23A)
This webinar summarizes filter design, criteria for filter selection, and how new filter choices can maximize your productivity.
## How Can We Help
In case of any questions, please submit a [customer support request](https://www.sigmaaldrich.com/US/en/support/customer-support)
or talk to our customer service team:
Email [custserv@sial.com](mailto:custserv@sial.com)
or call +1 (800) 244-1173
## Additional Support
- [Chromatogram Search](https://www.sigmaaldrich.com/chromatogram-search)
Use the Chromatogram Search to identify unknown compounds in your sample.
- [Calculators & Apps](https://www.sigmaaldrich.com/US/en/support/calculators-and-apps)
Web Toolbox - science research tools and resources for analytical chemistry, life science, chemical synthesis and materials science.
- [Customer Support Request](https://www.sigmaaldrich.com/US/en/support/customer-support)
Customer support including help with orders, products, accounts, and website technical issues.
- [FAQ](https://maestro.my.site.com/knowledgeportal/s/)
Explore our Frequently Asked Questions for answers to commonly asked questions about our products and services.
Top
__Sign In To Continue__
To continue reading please sign in or create an account.
Sign In__Don't Have An Account?__Register
Support[Customer Support](https://www.sigmaaldrich.com/US/en/support/customer-support)[Contact Us](https://www.sigmaaldrich.com/US/en/collections/offices)[FAQ](https://maestro.my.site.com/knowledgeportal/s/)[Safety Data Sheets (SDS)](https://www.sigmaaldrich.com/US/en/documents-search?tab=sds)[Certificates (COA/COO)](https://www.sigmaaldrich.com/US/en/documents-search?tab=coa)[Quality & Regulatory](https://www.sigmaaldrich.com/US/en/life-science/quality-and-regulatory-management)[Calculators & Apps](https://www.sigmaaldrich.com/US/en/support/calculators-and-apps)[Webinars](https://www.sigmaaldrich.com/US/en/collections/webinars)
Orders[Order Lookup](https://www.sigmaaldrich.com/US/en/order-lookup)[Quick Order](https://www.sigmaaldrich.com/US/en/quick-order)[Custom Products](https://www.sigmaaldrich.com/US/en/services/custom-products)[eCommerce Solutions](https://www.sigmaaldrich.com/US/en/life-science/ecommerce/ecommerce-solutions)
Company[About Us](https://www.sigmaaldrich.com/US/en/life-science/about-us)[Responsibility](https://www.sigmaaldrich.com/US/en/life-science/ssbi)[Events](https://www.sigmaaldrich.com/US/en/collections/events)[Press Releases](https://www.sigmaaldrich.com/US/en/collections/press)[Programs](https://www.sigmaaldrich.com/US/en/life-science/partnership-programs)[Careers](https://careers.merckgroup.com/global/en)[Offices](https://www.sigmaaldrich.com/US/en/collections/offices)
Social Media
[](https://www.linkedin.com/company/merck-life-science)
[](https://x.com/Merck_lifesci)
[](https://www.facebook.com/Merck.lifescience)
[](https://www.instagram.com/mercklifescience/)
[](https://www.youtube.com/@MerckLifeScience/featured)
MilliporeSigma
__Research. Development. Production.__
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.
[](https://www.sigmaaldrich.com/US/en)
[Sigma-Aldrich® Solutions](https://www.sigmaaldrich.com/US/en/life-science/sigma-aldrich)[BioReliance® Solutions](https://www.sigmaaldrich.com/US/en/life-science/bioreliance)[Millipore® Solutions](https://www.sigmaaldrich.com/US/en/life-science/millipore)[SAFC® Solutions](https://www.sigmaaldrich.com/US/en/life-science/safc)[Milli-Q® Solutions](https://www.sigmaaldrich.com/US/en/life-science/milliq)[Supelco® Solutions](https://www.sigmaaldrich.com/US/en/life-science/supelco)
© 2026 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved, including Text and Data Mining for AI training and similar technologies.
Reproduction of any materials from the site is strictly forbidden without permission.
[Site Use Terms](https://www.sigmaaldrich.com/US/en/life-science/legal/site-use-terms)|[Privacy Policy](https://www.sigmaaldrich.com/US/en/life-science/legal/privacy-statement)|[General Terms and Conditions of Sale](https://www.sigmaaldrich.com/US/en/life-science/legal/terms-and-conditions)|[Copyright Consent](https://www.sigmaaldrich.com/US/en/life-science/legal/copyright-consent) |[Site Map](https://www.sigmaaldrich.com/US/en/site-map)
An unknown error has occured.